PULDYSA Trademark

Trademark Overview


On Tuesday, January 8, 2019, a trademark application was filed for PULDYSA with the United States Patent and Trademark Office. The USPTO has given the PULDYSA trademark a serial number of 79253222. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2020. This trademark is owned by Santhera Pharmaceuticals (Schweiz) AG. The PULDYSA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of muscular dystrophy, muscular atrophy, metabolic diseases, neuromuscular diseases, respiratory diseases and ophthalmic diseases

Services in the field of scientific and industrial research, namely, the development of data processing programs for these purposes, in particular in the fields of cell cultures, cellular test systems for the evaluation of drugs, antibodies, test systems for the detection of pharmacologically active compounds, animal models for metabolic, neuromuscular, respiratory and ophthalmic diseases
puldysa

General Information


Serial Number79253222
Word MarkPULDYSA
Filing DateTuesday, January 8, 2019
Status700 - REGISTERED
Status DateTuesday, February 25, 2020
Registration Number5993051
Registration DateTuesday, February 25, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of muscular dystrophy, muscular atrophy, metabolic diseases, neuromuscular diseases, respiratory diseases and ophthalmic diseases
Translation of Words in MarkThe wording "PULDYSA" has no meaning in a foreign language.
Goods and ServicesServices in the field of scientific and industrial research, namely, the development of data processing programs for these purposes, in particular in the fields of cell cultures, cellular test systems for the evaluation of drugs, antibodies, test systems for the detection of pharmacologically active compounds, animal models for metabolic, neuromuscular, respiratory and ophthalmic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2019
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2019
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPratteln, CH CH4133

Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPratteln, CH CH4133

Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPratteln, CH CH4133

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 19, 2019REFUSAL PROCESSED BY IB
Thursday, February 28, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, March 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 9, 2019APPLICATION FILING RECEIPT MAILED
Saturday, March 23, 2019ASSIGNED TO EXAMINER
Saturday, March 23, 2019NON-FINAL ACTION WRITTEN
Sunday, March 24, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 2, 2019REFUSAL PROCESSED BY MPU
Wednesday, October 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 7, 2019ASSIGNED TO LIE
Monday, October 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2020REGISTERED-PRINCIPAL REGISTER
Monday, May 25, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, June 20, 2020FINAL DISPOSITION PROCESSED
Saturday, April 13, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 12, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, June 20, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 10, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 20, 2021NEW REPRESENTATIVE AT IB RECEIVED